EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells

Linjun Chen iD, Yixuan Huang, Yizhen Chen, Jiaxuan Chen, Xueye You, Laiyu Zou, Jiabing Chen, Zhixin Chen, Xiaozhong Wang, Yuehong Huang

Immunity, Inflammation and Disease · 2023

DOI: 10.1002/iid3.1076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Linjun Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Acute-On-Chronic Liver Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Fujian Province, the Startup Fund for scientific research of Fujian Medical University, the Joint Funds for the Innovation of Science and Technology, Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Acute‐on‐chronic liver failure (ACLF) causes organ system failures in patients and increases the risk of mortality. One of the main predictors of ACLF development in patients is the severity of systemic inflammation. The purpose of this study was to explore the effects of resolvin D1 (RvD1) on the rat model of ACLF.

Methods

The ACLF rats were induced by first intraperitoneally (ip) injecting CCl 4 and porcine serum for 6 weeks to establish the chronic liver injury, followed by once administration (ip) of lipopolysaccharide and d ‐galactose d ‐GalN to cause acute liver injury (ALI). An hour before the ALI‐induced treatment, rats were administrated (ip) with 0.9% saline or different doses of RvD1 (0.3 or 1 µg/kg). Afterward, the control and treated rats were killed and samples were collected. Biochemical analysis, hematoxylin‐eosin and Sirius red staining, flow cytometry assay, and real‐time polymerase chain reaction were used to assess the rat liver histopathological injury, the percentage of Treg cells in the spleen, and the messenger RNA (mRNA) levels of transcription factors and immunologic cytokines in liver.

Results

The necroinflammatory scores and the serum levels of transaminase significantly increased in ACLF rats compared with those in control rats. These impaired changes observed in ACLF rats could be attenuated by the administration of a low dose of RvD1 before the induction of ALI, which was associated with the increased proportion of regulatory T cells (Treg) in the spleen together with the increased gene expression ratio of Foxp3/RORγt and decreased mRNA level of Il‐17a and Il‐6 in the liver.

Conclusion

A low dose of RvD1 can promote the resolution of inflammation in ACLF rats by increasing the proportion of Treg cells. RvD1, therefore, may be used as a potential drug for the treatment of patients with ACLF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAcute-On-Chronic Liver FailureHumansRatsAnimalsSwineInflammationRNA, MessengerDocosahexaenoic Acids

Stichwörter der Autor:innen

IL-6Treg cellsacute-on-chronic liver failureanti-inflammationratsresolvin D1

Substanzen

RNA, Messengerresolvin D1Docosahexaenoic Acids

Autor:innen und Institutionen

  • Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Gastroenterology, Fujian Institute of Digestive Disease, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Internal Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Pathology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, Fuzhou, China.

ORCID-Profile: Linjun Chen

Förderung

  • the Natural Science Foundation of Fujian Province
  • the Startup Fund for scientific research of Fujian Medical University
  • the Joint Funds for the Innovation of Science and Technology, Fujian Province
  • the National Key Clinical Specialty Construction Projects of Fujian Province, China
  • the Construction Project of Fujian Province Minimally Invasive Medical Center

Zitieren

APA

Chen, L., Huang, Y., Chen, Y., Chen, J., You, X., Zou, L., Chen, J., Chen, Z., Wang, X., & Huang, Y. (2023). Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1076

Vancouver

Chen L, Huang Y, Chen Y, Chen J, You X, Zou L, et al. Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.1076

BibTeX
@article{Chen2023,
  author = {Chen, Linjun and Huang, Yixuan and Chen, Yizhen and Chen, Jiaxuan and You, Xueye and Zou, Laiyu and Chen, Jiabing and Chen, Zhixin and Wang, Xiaozhong and Huang, Yuehong},
  title = {Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  doi = {10.1002/iid3.1076}
}
Kostenlos starten →